Introduction
============

Podocytes, also known as visceral glomerular epithelial cells, serve a critical role in maintaining the normal structure and function of the glomerular filtration barrier ([@b1-etm-0-0-6313]). A wide variety of glomerular diseases can lead to many abnormal structural deformations of podocytes, including podocyte foot process fusion and detachment from the glomerular basement membrane (GBM), GBM thickening and ultimately a reduction in podocytes ([@b2-etm-0-0-6313]). Manifold stimuli can lead to podocyte abnormality and apoptosis, including immune-mediated and oxidative stress, hemodynamic changes, hyperglycemia and hyperlipidemia ([@b3-etm-0-0-6313]). To date, it has been established that glycation end-products and reactive oxygen species (ROS) induced by hyperglycemia can result in ultrastructural alterations of the glomerular filtration barrier in diabetic kidney diseases ([@b2-etm-0-0-6313]). Tight control of blood glucose can delay the development of diabetic kidney disease (DKD), but this alone is not capable of preventing progression of diabetic nephropathy to end-stage renal damage (ESRD).

Oxidative stress is a particularly important cause of kidney injury and podocyte apoptosis, activating a series of phosphorylated kinases. These, in turn, induce expression of downstream transcription factors and contribute to increased apoptosis and detachment of podocytes that line the GBM ([@b4-etm-0-0-6313]). As highly specialized and terminally differentiated cells, podocytes lack regenerative capabilities ([@b4-etm-0-0-6313],[@b5-etm-0-0-6313]). ROS include free radicals, such as superoxide, as well as non-radical species (i.e., H~2~O~2~). A certain concentration (200 µmol/l) of H~2~O~2~ results in cell apoptosis ([@b6-etm-0-0-6313]). It is well established that signaling pathways associated with podocyte apoptosis mainly include the caspase, cyclin kinase and other such pathways. Caspase-9 is the initiator caspase in the intrinsic or mitochrondrial caspase pathway that functions to activate downstream caspase-3 in response to apoptotic signals ([@b7-etm-0-0-6313]).

Honokiol (HNK) is a natural bi-phenolic compound isolated from the *Magnoliae officinalis* Cortex, which is commonly used in Traditional Chinese Medicine. Magnolia extracts have been confirmed to exhibit anti-oxidative, anti-microbial, anti-inflammatory, and antitumor pharmacological effects ([@b8-etm-0-0-6313]). It has also been reported that Magnolia extracts may protect contrast-induced nephropathy in rats through antioxidation and antiapoptosis in the kidney ([@b9-etm-0-0-6313]). Previous studies revealed that HNK protects against renal or myocardial ischemia/reperfusion injury via the suppression of oxidative stress, inducible nitric oxide synthase and inflammation in rats ([@b10-etm-0-0-6313]--[@b12-etm-0-0-6313]). Therefore, the aim of the present study was to explore the protective effects exerted by HNK on cultured mouse podocytes and its effect on apoptosis induced by H~2~O~2~. The potential associated molecular mechanisms/signaling pathways were also investigated.

Materials and methods
=====================

### Reagents

HNK (purity, 98.7%) was obtained from the National Institute for the Control of Pharmaceutical and Biological Products of China (Beijing, China). H~2~O~2~ was obtained from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany). A CellTiter 96^®^ AQueous Non-Radioactive Cell Proliferation Assay (MTS) was procured from Promega Corporation (Madison, WI, USA). Annexin V-FITC Apoptosis Detection kit was purchased from BD Biosciences (Franklin Lakes, NJ, USA). Polyclonal antibodies against cleaved caspase-3 (cat. no. 9664), cleaved-caspase-9 (cat. no. 7237), protein kinase B (Akt; cat. no. 4685), extracellular signal-regulated kinase (Erk) 1/2 (cat. no. 4695), phosphorylated (p-)Akt (cat. no. 4060), p-Erk ½ (cat. no. 4376) and β-actin (cat. no. 4970S) were all obtained from Cell Signaling Technology, Inc. (Danvers, MA, USA).

### Cell culture

Conditionally immortalized mouse podocytes were purchased from Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Cells were cultured in RPMI 1640 (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% heat-inactivated fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.), 25 mM glucose and antibiotics (penicillin and streptomycin) at 37°C in humidified air with 5% CO~2~. The morphology of podocytes treated with H~2~O~2~ in the absence or presence of different concentrations (1.25, 5 and 20 µM) of HNK was observed using images obtained from an inverted microscope (Olympus IX81; Olympus Corporation, Tokyo, Japan; magnification, ×100).

### Viability evaluation

Cultured mouse podocytes (1×10^4^ cells/well in 96-well plate) were pre-treated with HNK (0, 1.25, 5 and 20 µM) for 2 h at 37°C and further incubated in the presence of 100 µM H~2~O~2~ for 24 h at 37°C The groups (excluding group 1; 0 µM H~2~O~2~+0 µM HNK) were pretreated with HNK 2 h prior to the addition of H~2~O~2~ and then sustained with the same concentration of HNK for 24 h to assess the effects of HNK. Additionally, group 6 was treated with 20 µM HNK without H~2~O~2~ in order to assess if a high concentration of HNK affected the viability of cells. Cell viability was evaluated using an MTS assay. Following incubation in the appropriate medium, 20 µl phenazine methosulfate (an electron coupling reagent) was added to each well for 1 h at 37°C in 5% CO~2~ and absorbance was measured at 490 nm.

### Flow cytometry analysis

At 24 h following H~2~O~2~ treatment, the apoptosis of cells treated with or without HNK were monitored. Annexin V binding and propidium iodide (PI) staining were determined by flow cytometry. Cells were washed with PBS twice, and double stained at 37°C with the fluorescein isothiocyanate (FITC)-conjugated Annexin V protein and PI for 20 min. Flow cytometry was performed using a 488 nm laser coupled to a flow cytometer (FACSCalibur; BD Biosciences, San Jose, CA, USA) to detect intact cells (FITC^−^/PI^−^), apoptotic cells (FITC^+^/PI^−^) and necrotic cells (FITC^−^/PI^+^). The data was analyzed using BD FACSDiva 6.0 software (BD Biosciences).

### Western blotting

Cultured mouse podocytes (5×10^6^/10-cm dish) were pre-treated with different concentrations (0, 1.25, 5 and 20 µM) of HNK for 2 h and followed by 100 µM H~2~O~2~ for 24 h at 37°C. Cells were collected and lysed with lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton, 1% NP-40, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM leupeptin, 1 mM phenylmethylsulfonyl fluoride) for 30 min at 4°C. Extracted protein in each cell lysate was determined using a bicinchoninic acid protein assay kit (Pierce; Thermo Fisher Scientific, Inc.). Proteins were transferred to a polyvinylidene difluoride membrane and blocked with 5% non-fat dry milk in PBS with 0.02% v/v Tween-20 (PBS-Tween) for 2 h at room temperature. The membrane was incubated for 16 h at 4°C with the aforementioned primary antibodies at a dilution of 1:1,000. However, anti-β-actin was used at a dilution of 1:2,000. The membrane was washed and subsequently incubated for 1 h at room temperature with a peroxidase-labeled Rabbit anti-Goat IgG antibody (cat. no. SA00001-4; 1:5,000; ProteinTech Group, Inc., Chicago, IL, USA). Following further washing, the membrane was analyzed using an enhanced chemiluminescence kit (Pierce; Thermo Fisher Scientific, Inc.).

### Extraction of total RNA and reverse transcription-polymerase chain reaction (RT-PCR)

Total RNA was extracted from cell lines using RNAiso Plus (Takara Bio, Inc., Otsu, Japan) according to the manufacturer\'s instructions. Samples were stored at −80°C prior to further use. First chain cDNA synthesis was performed using the PrimeScript™ RT Reagent kit (Takara Bio, Inc.) according to the manufacturer\'s instructions and PCR was subsequently performed using the SYBR Premix Ex Taq kit (Takara Bio, Inc.). Primer sequences used were as follows: Caspase-3 forward, 5′-CGTGGTTCATCCAGTCCCTTT-3′ and reverse, 5′-ATTCCGTTGCCACCTTCCT-3′; caspase-9 forward, 5′-ATCGACCCTCCGCCAGA-3′ and reverse, 5′-CAAAGGAAGCAGAACCCAT-3′; and β-actin forward, 5′-CTCTTCCAGCCTTCCTTCCT-3′ and reverse, 5′-CACCTTCACCGTTCCAGTTT-3′. The thermocycling conditions were as follows: 95°C for 5 min, followed by 40 cycles at 95°C for 15 sec, 60°C for 20 sec and 72°C for 20 sec, and a final extension at 72°C for 10 min.

### Statistical analysis

All experiments were performed in triplicate and data are presented as means ± standard deviation. Statistical significance was determined using one-way analysis of variance followed by a Fisher\'s least significant difference test. Statistical analyses were performed using SPSS 16.0 software (SPSS, Inc., Chicago, IL, USA). P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Effects of HNK on viability of mouse podocytes treated with H~2~O~2~

Cultured mouse podocytes were pre-treated with HNK (0, 1.25, 5, 20 µM) for 2 h and further incubated with 100 µM H~2~O~2~ (excluding groups 1 and 6) for 24 h. Cell viability was evaluated via MTS assay. Results revealed that mouse podocytes retained almost the same levels of viability following exposure to incubation conditions with HNK concentrations of 20 µM (group 6) compared with the normal control (group 1), suggesting that HNK did not affect podocyte viability at certain concentrations. However, as 100 µM H~2~O~2~ significantly reduced cell viability (group 2), the OD value was only \~25% of that in group 1 (P\<0.01). Following pre-treatment with different concentrations of HNK, the rate of cell viability increased in a concentration-dependent manner. OD values of groups treated with HNK at low, medium and high concentrations were 1.39 (P\<0.01), 2.5 (P\<0.01) and 3.73 times (P\<0.01) higher, respectively, when compared with the group treated with H~2~O~2~ alone ([Fig. 1](#f1-etm-0-0-6313){ref-type="fig"}).

### Effect of HNK on morphologic changes in podocytes treated with H~2~O~2~

Following pre-treatment with different concentrations of HNK for 2 h and 100 µM H~2~O~2~ for 24 h, podocytes were observed and photographed using an inverted microscope. Microscopic observation revealed that 100 µM H~2~O~2~ markedly affected cell physiology. Numerous dead podocytes were noted floating in the supernatant, whereas weakly adhered cells were observed as opaque, black-spotted masses. Podocytes treated with HNK alone exhibit a morphology similar to the control group with only a few floating cells in the supernatant. Following treatment with H~2~O~2~ and different concentrations of HNK for 24 h, the morphology of podocytes improved in a dose-dependent manner and cells gradually became more transparent ([Fig. 2](#f2-etm-0-0-6313){ref-type="fig"}).

### Effects of HNK on podocyte apoptosis induced by H~2~O~2~

Results of flow cytometry revealed that the ratio of apoptotic podocytes did not markedly differ between control and 20 µM HNK treatment groups following 24 h. Although H~2~O~2~ typically results in an increased apoptotic ratio, treatment with different concentrations of HNK resulted in markedly decreases in the ratio of apoptosis in podocytes. Compared with the H~2~O~2~-treated group, the ratio of apoptosis in groups treated with low, medium and high concentrations of HNK were decreased gradually. However, the apoptosis ratio of groups treated with high concentrations of HNK remained slightly higher than that of the control group ([Fig. 3](#f3-etm-0-0-6313){ref-type="fig"}).

### Effects of HNK on the expression of caspase-3 and caspase-9

Caspases (proteases) serve an important role in extrinsic and intrinsic apoptotic pathways. The RT-PCR results indicated that mRNA expression of caspase-3 and caspase-9 both increased in podocytes treated with H~2~O~2~ compared with control cells. Additionally, although mRNA levels of caspase 9 were marginally higher in cells treated with 100 µM H~2~O~2~ +1.25 µM HNK than in those treated with 100 µM H~2~O~2~ alone, HNK gradually downregulated expression of cleaved caspase-3 and caspase-9 mRNA in a concentration from 5 to 20 µM ([Fig. 4](#f4-etm-0-0-6313){ref-type="fig"}). Furthermore, western blotting analysis of cleaved caspase-3 and caspase-9 protein levels produced similar findings as those of their mRNA levels, although the protein level of cleaved caspase-3 was margnally higher in cells treated with 100 µM H~2~O~2~ +1.25 µM HNK than in those treated with 100 µM H~2~O~2~ alone ([Fig. 5](#f5-etm-0-0-6313){ref-type="fig"}). These results suggested an obvious inhibition of cleaved caspase-3, −9 protein and caspase-3, −9 mRNA expression by HNK.

### Mechanisms associated with HNK-inhibition of H~2~O~2~-induced oxidative stress in mouse podocytes

Recent findings have demonstrated that Akt and Erk signaling pathways is associated with the regulation of apoptosis in various of cell types, tissues and organs in many diseases ([@b13-etm-0-0-6313]--[@b15-etm-0-0-6313]). In the present study, protein levels of total Akt and Erk 1/2 exhibited no marked changes, whereas levels of p-Akt and p-Erk 1/2 appeared to increase following HNK treatment, peaking at the highest concentration of HNK (20 µM). However, levels of p-Akt and p-Erk 1/2 did not exhibit any marked declines following H~2~O~2~ treatment alone. To some extent, p-Akt and p-Erk 1/2 levels increased in cells treated with H~2~O~2~ compared with the control group, suggesting an inconsistent tendency associated with the expression of caspase in cells pre-treated with HNK ([Fig. 5](#f5-etm-0-0-6313){ref-type="fig"}).

Discussion
==========

An increased amount of urinary protein, termed albuminuria (typically 67 kDa), is among the earliest signs of DKD and strongly correlates with progression towards ESRD ([@b2-etm-0-0-6313]). The glomerular filtration barrier consists of three layers: Capillary endothelium, GBM and the glomerular epithelial cell (or podocyte) layer. Numerous studies ([@b16-etm-0-0-6313]--[@b18-etm-0-0-6313]) concerning DKD emphasized damage to mesangial cells and the glomerular basement membrane. Glomerular hypertrophy, mesangial matrix expansion and GBM thickening are classic signs of diabetic glomerular diseases ([@b19-etm-0-0-6313]). Previous evidence ([@b20-etm-0-0-6313]--[@b22-etm-0-0-6313]) have demonstrated that the onset of proteinuria is closely associated with pathological changes in podocytes, such as hypertrophy, detachment, apoptosis and epithelial-to-mesenchymal transition.

ROS promotes renal injury, exacerbating the progression of kidney disease ([@b2-etm-0-0-6313]). Previous studies ([@b23-etm-0-0-6313],[@b24-etm-0-0-6313]) have demonstrated that ameliorating oxidative stress through treatment with antioxidants may be an effective strategy for reducing diabetic complications. Several clinical ([@b25-etm-0-0-6313],[@b26-etm-0-0-6313]) trials have confirmed the effects of certain antioxidants on the prevention of diabetic complications. Under normal physiological conditions, the levels of cellular ROS remain stable in a dynamic equilibrium. The destruction of this balance promotes ROS accumulation, which causes molecular, cellular and clinical abnormalities ([@b6-etm-0-0-6313]). In the present study, data from the MTS assay revealed that 100 µM H~2~O~2~ significantly reduced cell viability, with the OD value being \~25% of the normal control group with identical flow cytometry outcomes. In addition, observation under inverted microscopy indicated that 100 µM H~2~O~2~ significantly affected cellular physiology.

HNK serves an anti-oxidative role by inhibiting NADPH oxidase, myeloperoxidase and cyclooxygenase while increasing glutathione peroxidase activity in neutrophils to promote metabolism of H~2~O~2~ ([@b27-etm-0-0-6313]). The present study demonstrated that H~2~O~2~ reduces the ratio of viable podocytes as well as increases the ratio of cell apoptosis. Additionally, cultured mouse podocytes were pre-treated with HNK (0, 1.25, 5 and 20 µM) for 2 h and further incubated in 100 µM H~2~O~2~ for 24 h. The effect of HNK on peroxide-induced podocyte apoptosis was subsequently investigated. Podocytes were also treated with high concentrations (20 µM) of HNK alone to observe the influence of HNK on cellular viability and apoptosis as well. Following 24 h treatment with different concentrations of HNK and 100 µM H~2~O~2~, the morphology of adherent podocytes improved in a dose-dependent manner compared with H~2~O~2~ treatment alone. In addition, HNK treatment alone did not markedly alter podocyte physiology in comparison with the control group. These results demonstrated that HNK, within certain safe ranges of concentration, can protect podocytes from damage induced by oxidative stress. MTS assay and flow cytometry further confirmed that HNK treatment lead to significantly lower apoptotic ratios and greater viability rates in podocytes. Nonetheless, the ratio of apoptosis in cells treated with HNK at high concentrations remained slightly higher as compared with the control group.

Casepase-9 is generally considered to be an initial mediator of apoptosis induced by H~2~O~2~ ([@b28-etm-0-0-6313]). The eventual release of cytochrome C promotes activation of caspase-3 (which can also be activated to strengthen caspase-3), thus resulting in activation of caspase-associated DNase. Activated DNase degrades DNA to mere fragments. This is one important marker of cellular apoptosis ([@b28-etm-0-0-6313]). In the present study, RT-PCR and western blotting results confirmed that the expression of both mRNA and protein of cleaved caspase-3 and −9 markedly increased in podocytes treated with H~2~O~2~. Pretreatment with HNK markedly downregulated expression of both protein and mRNA of caspase-3 and −9 in a concentration-dependent manner.

Previous studies also reported the anti-apoptotic effects of hepatocyte growth factor (HGF) on podocytes *in vitro*. HGF stimulation resulted in the phosphorylation of Akt and Erk, and induction of an X-linked inhibitor of apoptosis protein (XIAP) in podocytes ([@b29-etm-0-0-6313]). Furthermore, phosphorylation of Akt and Erk 1/2 was attenuated, whereas the expression of cleaved caspase-3 and the number of TUNEL positive cells was enhanced in vascular endothelial cells exposed to H~2~O~2~ ([@b30-etm-0-0-6313]). In another study, cultured mouse neural progenitor cells were treated with H~2~O~2~, apoptotic signaling pathways were activated and the phosphorylation of Akt and Erk decreased. Astaxanthin pretreatment, however, significantly inhibited H~2~O~2~-mediated caspase activation ([@b31-etm-0-0-6313]). The activation of phosphorylation of Erk 1/2, which blocked the release of cytochrome C from mitochondria, resulted in inhibition of caspase-9 and −3 activation. The ratio of apoptosis also decreased ([@b31-etm-0-0-6313]). The phosphoinositide 3-kinase (PI3K)/Akt/glycogen synthase kinase (GSK)-3 signal transduction pathway is a vital modality of intracellular membrane receptor signal transduction and serves an important role in the regulation of apoptosis in a variety of organs ([@b32-etm-0-0-6313]). Akt is a serine/threonine protein kinase characterized by multiple sites of phosphorylation. PI3K inhibits the downstream apoptosis-related protein GSK-3β by enhancing the activation of Akt, thus having an anti-apoptotic effect. GSK-3 serves a critical role in regulation of apoptosis, which can inhibit transcription factors, such as heat shock factor-1 (a cyclic adenosine monophosphate binding protein) and activate members of the caspase family, leading to apoptosis ([@b32-etm-0-0-6313],[@b33-etm-0-0-6313]).

The present data indicated that as HNK concentration increased, total Akt and Erk 1/2 protein levels did not markedly change. However, levels of p-Akt and Erk 1/2 gradually increased, peaking at 20 µM HNK in a concentration-dependent manner. As the expression of cleaved caspase-3 and −9 gradually decreased, levels of p-Akt and -Erk 1/2 increased with HNK treatment. Notably, in the present study, levels of p-Akt and -Erk 1/2 in the group treated with H~2~O~2~ alone did not significantly decrease as compared with the normal control group. This phenomenon seemed inconsistent with the tendency of the expression of caspase in HNK-treated cells and contradicted the results of MTS and flow cytometry. It was speculated that the potency of H~2~O~2~ inevitably weakens as time passes, and cells exhibit a certain degree of self-repair capacity. Levels of p-Akt and Erk 1/2 therefore increased slightly under H~2~O~2~ treatment alone following 24-h incubation. Nevertheless, the effects observed in the present study are not necessarily indicative of a cause-and-effect relationship. Furthermore, it is necessary to interfere with Akt and Erk at the genetic level to confirm the targets of HNK in H~2~O~2~-treated podocytes.

In conclusion, the present study confirmed that HNK serves a vital role in protecting against apoptosis in podocytes treated with H~2~O~2~ by means of inhibiting caspase-3 and −9 activation as well as enhancing phosphorylation of Akt and Erk 1/2. HNK may have potential as a treatment for kidney diseases exacerbated by oxidative stress damage.

Not applicable.

Funding
=======

The present study was supported by the Zhejiang Provincial Natural Science Foundation of China (LY14H070002 and LQ16H070001), the Zhejiang Provincial Medical Science and Technology Program (Backbone Project of Platform Program; 2015RCA013) and the Zhejiang Provincial Administration of traditional Chinese Medicine Project (2015ZA058).

Availability of data and materials
==================================

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors\' contributions
=======================

FW and HY conceived and designed the study, wrote the protocol, performed the experiments, analyzed the data, performed the literature search and approved the final manuscript. FZ, JZ and HL supervised the research and contributed to the flow cytometric analysis and cell viability evaluation. XL, LL and ST were involved in data acquisition and helped perform the cell biology experiments. FW wrote the first draft of the manuscript, HL helped revise the manuscript. All co-authors approved the final version of the manuscript. FW and HY had full access to all the data in this study and take responsibility for the integrity of the data.

Ethics approval and consent to participate
==========================================

Not applicable.

Consent for publication
=======================

Not applicable.

Competing interests
===================

The authors declare that they have no competing interests.

![Effect of HNK on the viability of podocytes treated with H2O2. Podocytes (1×104 cells/well) were incubated with HNK at different concentrations and 100 µM H2O2 for 24 h. Cell viability was determined via MTS assay. Data are represented as the mean ± the standard error of the mean (n=3). \*P\<0.05, \*\*P\<0.01 vs. normal control (group 1); ◊◊P\<0.01 vs. H2O2 treated alone (group 2). HNK, honokiol; OD, optical density.](etm-16-02-1278-g00){#f1-etm-0-0-6313}

![Cell morphologic changes of podocytes treated with HNK and 100 µM H2O2 as viewed under light microscopy. Following treatment with HNK and 100 µM H2O2 for 24 h, cells were photographed under light microscopy. Cells were divided into the following treatment groups: (A) 0 µM H2O2 + 0 µM HNK (normal control), (B) 0 µM H2O2 + 20 µM HNK, (C) 100 µM H2O2 + 0 µM HNK, (D) 100 µM H2O2 + 1.25 µM HNK, (E) 100 µM H2O2 + 5 µM HNK and (F) 100 µM H2O2 + 20 µM HNK. The magnification scale was 100 µm when taking photos.](etm-16-02-1278-g01){#f2-etm-0-0-6313}

![The protective effect of HNK on apoptosis in podocytes treated with H2O2. Podocytes were cultured under different concentrations (0-20 µM) of HNK and H2O2. Following 24 h, podocytes were collected and cell apoptosis was detected via Annexin V/PI staining methods with flow cytometry. Experiments were performed in triplicate. Cells were divided into the following treatment groups: (A) 0 µM H2O2 + 0 µM HNK (normal control), (B) 0 µM H2O2 + 20 µM HNK, (C) 100 µM H2O2 + 0 µM HNK, (D) 100 µM H2O2 + 1.25 µM HNK, (E) 100 µM H2O2 + 5 µM HNK and (F) 100 µM H2O2 + 20 µM HNK. HNK, honokiol; PI, propidium iodide; FITC, fluorescein isothiocyanate.](etm-16-02-1278-g02){#f3-etm-0-0-6313}

![Detection of caspase-3 and −9 in podocytes treated with HNK and H2O2. Podocytes were treated with different concentrations of HNK and 100 µM H2O2 for 24 h. Expression of caspase-3 and −9 mRNA was evaluated by reverse transcription-polymerase chain reaction. Cells were divided into the following treatment groups: 1, 0 µM H2O2 + 0 µM HNK (normal control); 2, 100 µM H2O2 + 0 µM HNK; 3, 100 µM H2O2 +1.25 µM HNK; 4, 100 µM H2O2 + 5 µM HNK; and 5, 100 µM H2O2 + 20 µM HNK. HNK, honokiol.](etm-16-02-1278-g03){#f4-etm-0-0-6313}

![Detection of cleaved caspase-3 and −9 protein, p-Akt and p-Erk 1/2 protein levels in podocytes treated with HNK and H2O2. Levels of cleaved caspase-3 and −9 protein, Akt, Erk 1/2, p-Akt and p-Erk 1/2 protein were detected by western blotting. Cells were divided into the following treatment groups: 1, 0 µM H2O2 + 0 µM HNK (normal control); 2, 100 µM H2O2 + 0 µM HNK; 3, 100 µM H2O2 +1.25 µM HNK; 4, 100 µM H2O2 + 5 µM HNK; and 5, 100 µM H2O2 + 20 µM HNK. HNK, honokiol. p, phosphorylated; Akt, protein kinase B; Erk, extracellular signal-regulated kinase; HNK, honokiol.](etm-16-02-1278-g04){#f5-etm-0-0-6313}
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